Drug intelligence / Profile preview

genistein + cholecalciferol + menaquinone-7

Development stage
Preclinical
Lead developer
NattoPharma
Modality
Small Molecules
Administration
Oral
01

Overview

This product is a multi-ingredient dietary supplement combining genistein, cholecalciferol (vitamin D3), and menaquinone-7 (vitamin K2-7) intended primarily to support bone health and mineralization. Genistein is an isoflavone that exerts estrogen receptor–mediated and cytokine-modulating effects, decreasing receptor activator of nuclear factor kappa B ligand (RANKL), increasing osteoprotegerin, and promoting osteoblast differentiation while inhibiting osteoclast activity, thereby reducing bone resorption and enhancing bone formation.[1] Cholecalciferol increases intestinal absorption of calcium and phosphate and, together with genistein and other cofactors, contributes to improved bone mineral density in postmenopausal women.[1] Menaquinone-7 serves as a cofactor for gamma-glutamyl carboxylase, activating vitamin K–dependent proteins such as osteocalcin and matrix Gla protein, which promote calcium deposition in bone and limit ectopic vascular calcification, and it works synergistically with vitamin D3 to modulate osteocalcin, RANK, RANKL, and osteoprotegerin expression.[1][3]

02

Targets

MGP (Matrix Gla protein)ESR2 (ERβ)GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)RANKL (Receptor Activator for Nuclear Factor-kappa B Ligand)VDR (Vitamin D receptor)CYP2C8 (Cytochrome P450 2C8)

Beyond the preview

Go deeper on genistein + cholecalciferol + menaquinone-7.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on genistein + cholecalciferol + menaquinone-7.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call